Reply: BAL lymphocyte percentage is as good as the company it keeps
- PMID: 33602877
- DOI: 10.1183/13993003.00092-2021
Reply: BAL lymphocyte percentage is as good as the company it keeps
Conflict of interest statement
Conflict of interest: N. Adderley has nothing to disclose. Conflict of interest: C.J. Humphreys has nothing to disclose. Conflict of interest: H. Barnes has nothing to disclose. Conflict of interest: Z.A. Premji has nothing to disclose. Conflict of interest: K.A. Johannson reports personal fees for advisory board work and lectures, non-financial support and other from Boehringer Ingelheim, personal fees for lectures from Hoffman-La Roche Ltd, grants from The Chest Foundation, University of Calgary Cumming School of Medicine, UCB Biopharma SPRL and Pulmonary Fibrosis Society of Calgary, personal fees for consultancy from Blade Therapeutics and Theravance, personal fees for consultancy and non-financial support from Three Lakes Foundation, outside the submitted work.
Comment on
-
Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis.Eur Respir J. 2020 Aug 6;56(2):2000206. doi: 10.1183/13993003.00206-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32265306
-
Comment on: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis.Eur Respir J. 2021 Feb 17;57(2):2004347. doi: 10.1183/13993003.04347-2020. Print 2021 Feb. Eur Respir J. 2021. PMID: 33602876 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources